ArticleDrug and alcohol dependence2007
The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.
Article in Drug and alcohol dependence, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
62 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review.Journal of substance abuse treatment · 2009Pooled it
- Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections.Journal of substance abuse treatment · 2015Trial
- The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.Journal of studies on alcohol and drugs · 2014Trial
- Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.Psychiatric services (Washington, D.C.) · 2021Article
- Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020Review
- The use of off-label medications in substance abuse treatment programs.Substance abuse · 2020Article
- State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder.Psychiatric services (Washington, D.C.) · 2018Article
- Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.Medical care · 2017Article
- Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.The journal of behavioral health services & research · 2017Article
- The Classification of Substance Use Disorders: Historical, Contextual, and Conceptual Considerations.Behavioral sciences (Basel, Switzerland) · 2016Review
- Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.Journal of substance abuse treatment · 2016Article
- Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.Journal of substance abuse treatment · 2015Article
- Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis.Drug and alcohol dependence · 2015Article
- How do providers serving American Indians and Alaska Natives with substance abuse problems define evidence-based treatment?Psychological services · 2015Article
- Rural substance use treatment centers in the United States: an assessment of treatment quality by location.The American journal of drug and alcohol abuse · 2015Article
- A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.Annals of the New York Academy of Sciences · 2014Review
- Examining the sustainment of the Adolescent-Community Reinforcement Approach in community addiction treatment settings: protocol for a longitudinal mixed method study.Implementation science : IS · 2014Article
- Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.American journal of public health · 2014Article
- Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.Addictive behaviors · 2014Article
- Climate for innovation, 12-step orientation, and tobacco cessation treatment.Journal of substance abuse treatment · 2014Article
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Despite growing interest in closing the "research to practice gap", there are few data on the availability of medications in American substance abuse treatment settings. Recent research suggests that organizational characteristics may be associated with medication availability. It is unclear if the availability of medications can be conceptualized in terms of "technology clusters", where the availability of a medication is positively associated with the likelihood that other medications are also offered. Using data from 403 privately funded and 363 publicly funded specialty substance abuse treatment centers in the US, this research models the availability of agonist medications, naltrexone, disulfiram, and SSRIs. Bivariate logistic regression models indicated considerable variation in adoption across publicly funded non-profit, government-owned, privately funded non-profit, and for-profit treatment centers. Some of these differences were attenuated by organizational characteristics, such as accreditation, the presence of staff physicians, and the availability of detoxification services. There was some evidence that naltrexone, disulfiram, and SSRIs represent a group of less intensely regulated medications that is distinct from more intensely regulated medications. These types of medications were associated with somewhat different correlates. Future research should continue to investigate the similarities and differences in the predictors of medication availability across national contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.